{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["alkaloids", "apoptosis", "cancer therapeutics", "medicinal plants", "molecular activity"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "28208712", "DateCompleted": {"Year": "2017", "Month": "05", "Day": "09"}, "DateRevised": {"Year": "2018", "Month": "12", "Day": "07"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "02", "Day": "08"}], "Language": ["eng"], "ELocationID": ["250", "10.3390/molecules22020250"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "22", "Issue": "2", "PubDate": {"Year": "2017", "Month": "Feb", "Day": "08"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Emerging Cytotoxic Alkaloids in the Battle against Cancer: Overview of Molecular Mechanisms.", "Abstract": {"AbstractText": ["Considered as the second deadliest disease globally, cancer has captured the attention of researchers who have been trying with perseverance to decode its hidden aspects, to find new prognosis methods, and to develop better and more effective treatments. Plants have continuously offered an excess of unique secondary metabolites with remarkable biological applications. Alkaloids, one of the most abundant metabolites, constitute a large conglomerate of basic heterocyclic nitrogen-containing natural compounds which are normally produced by plants as toxic substances. Out of the 27,000 different alkaloids, more than 17,000 have displayed diversified pharmacological properties including anticancer activities. These metabolites have been classified either according to their chemical structures or their taxonomic origin. None of the researched alkaloids have been classified according to their molecular mechanism of action against cancer. In fact, only a fraction of the tremendous number of anticancer alkaloids has been copiously mentioned in journals. Here, we aim to provide a summary of the literature on some of the promising anticancer alkaloids that have not been well discussed previously and to classify them according to their molecular mechanisms of action. This review will provide a better understanding of the anticancer mechanisms of these promising natural products that are a rich reservoir for drug discovery."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology and Department of Anatomy, Cell Biology and Physiological Sciences, American University of Beirut, Beirut 1107 2020, Lebanon. zeina1hb@gmail.com."}], "LastName": "Habli", "ForeName": "Zeina", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology and Department of Anatomy, Cell Biology and Physiological Sciences, American University of Beirut, Beirut 1107 2020, Lebanon. gjt01@mail.aub.edu."}], "LastName": "Toumieh", "ForeName": "Georgio", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology and Department of Anatomy, Cell Biology and Physiological Sciences, American University of Beirut, Beirut 1107 2020, Lebanon. mf53@aub.edu.lb."}], "LastName": "Fatfat", "ForeName": "Maamoun", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Medicine, Saba University School of Medicine, Saba, Dutch Caribbean 5016121, The Netherlands. omar2.rahal@gmail.com."}], "LastName": "Rahal", "ForeName": "Omar Nasser", "Initials": "ON"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology and Department of Anatomy, Cell Biology and Physiological Sciences, American University of Beirut, Beirut 1107 2020, Lebanon. amro@aub.edu.lb."}], "LastName": "Gali-Muhtasib", "ForeName": "Hala", "Initials": "H"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Biological Products"}, {"RegistryNumber": "EC 3.4.22.-", "NameOfSubstance": "Caspases"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Alkaloids"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Biological Products"}, {"QualifierName": ["metabolism"], "DescriptorName": "Caspases"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Cycle Checkpoints"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["drug effects"], "DescriptorName": "DNA Damage"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Research"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Hanahan D., Weinberg R.A. Hallmarks of cancer: The next generation. Cell. 2011;144:646\u2013674. doi: 10.1016/j.cell.2011.02.013.", "ArticleIdList": ["10.1016/j.cell.2011.02.013", "21376230"]}, {"Citation": "Cavallo F., de Giovanni C., Nanni P., Forni G., Lollini P.L. The immune hallmarks of cancer. Cancer Immunol. Immunother. 2011;60:319\u2013326. doi: 10.1007/s00262-010-0968-0.", "ArticleIdList": ["10.1007/s00262-010-0968-0", "PMC3042096", "21267721"]}, {"Citation": "Ashkenazi A. Directing cancer cells to self-destruct with pro-apoptotic receptor agonists. Nat. Rev. Drug Discov. 2008;7:1001\u20131012. doi: 10.1038/nrd2637.", "ArticleIdList": ["10.1038/nrd2637", "18989337"]}, {"Citation": "Morin P.J. Drug resistance and the microenvironment: Nature and nurture. Drug Resist. Updates. 2003;6:169\u2013172. doi: 10.1016/S1368-7646(03)00059-1.", "ArticleIdList": ["10.1016/S1368-7646(03)00059-1", "12962682"]}, {"Citation": "Halberstein R.A. Medicinal Plants: Historical and Cross-Cultural Usage Patterns. Ann. Epidemiol. 2005;15:686\u2013699. doi: 10.1016/j.annepidem.2005.02.004.", "ArticleIdList": ["10.1016/j.annepidem.2005.02.004", "15921929"]}, {"Citation": "Bishayee A., Sethi G. Bioactive natural products in cancer prevention and therapy: Progress and promise. Semin. Cancer Biol. 2016;40:1\u20133. doi: 10.1016/j.semcancer.2016.08.006.", "ArticleIdList": ["10.1016/j.semcancer.2016.08.006", "27565447"]}, {"Citation": "Das A., Dhanjal J.K. Medicinal plants, a gold mine of anticancer compounds. Am. Int. J. Res. Formal Appl. Nat. Sci. 2015;9:14\u201323."}, {"Citation": "Lu J.J., Bao J.L., Chen X.P., Huang M., Wang Y.T. Alkaloids isolated from natural herbs as the anticancer agents. Evid. Based Complement. Altern. Med. 2012;2012:485042. doi: 10.1155/2012/485042.", "ArticleIdList": ["10.1155/2012/485042", "PMC3440018", "22988474"]}, {"Citation": "Solanki R. Impurity profiling of active pharmaceutical ingredients and finished drug products. Int. J. Drug Res. Technol. 2012;2:231\u2013238."}, {"Citation": "Wink M. Modes of Action of Herbal Medicines and Plant Secondary Metabolites. Medicines. 2015;2:251\u2013286. doi: 10.3390/medicines2030251.", "ArticleIdList": ["10.3390/medicines2030251", "PMC5456217", "28930211"]}, {"Citation": "Mith\u00f6fer A., Boland W. Plant Defense Against Herbivores: Chemical Aspects. Annu. Rev. Plant Biol. 2012;63:431\u2013450. doi: 10.1146/annurev-arplant-042110-103854.", "ArticleIdList": ["10.1146/annurev-arplant-042110-103854", "22404468"]}, {"Citation": "Semwal D.K., Semwal R.B., Vermaak I., Viljoen A. From arrow poison to herbal medicine\u2014The ethnobotanical, phytochemical and pharmacological significance of Cissampelos (Menispermaceae) J. Ethnopharmacol. 2014;155:1011\u20131128. doi: 10.1016/j.jep.2014.06.054.", "ArticleIdList": ["10.1016/j.jep.2014.06.054", "24997389"]}, {"Citation": "Dias D.A., Urban S., Roessner U. A historical overview of natural products in drug discovery. Metabolites. 2012;2:303\u2013336. doi: 10.3390/metabo2020303.", "ArticleIdList": ["10.3390/metabo2020303", "PMC3901206", "24957513"]}, {"Citation": "Zenk M.H., Juenger M. Evolution and current status of the phytochemistry of nitrogenous compounds. Phytochemistry. 2007;68:2757\u20132772. doi: 10.1016/j.phytochem.2007.07.009.", "ArticleIdList": ["10.1016/j.phytochem.2007.07.009", "17719615"]}, {"Citation": "Aniszewski T. Alkaloids-Secrets of Life. 1st ed. Elsevier; Oxford, UK: 2007. pp. 1\u2013352."}, {"Citation": "Mohan K., Jeyachandran R. Alkaloids as anticancer agents. Ann. Phytomed. 2012;1:46\u201353."}, {"Citation": "Millimouno F.M., Dong J., Yang L., Li J., Li X. Targeting apoptosis pathways in cancer and perspectives with natural compounds from mother nature. Cancer Prev. Res. 2014;7:1081\u20131107. doi: 10.1158/1940-6207.CAPR-14-0136.", "ArticleIdList": ["10.1158/1940-6207.CAPR-14-0136", "25161295"]}, {"Citation": "Wen G., Qu X.X., Wang D., Chen X.X., Tian X.C., Gao F., Zhou X.L. Recent advances in design, synthesis and bioactivity of paclitaxel-mimics. Fitoterapia. 2016;110:26\u201337. doi: 10.1016/j.fitote.2016.02.010.", "ArticleIdList": ["10.1016/j.fitote.2016.02.010", "26906104"]}, {"Citation": "Said R. Pharmacokinetic evaluation of vincristine for the treatment of lymphoid malignancies. Expert Opin. Drug Metab. Toxicol. 2014;10:483\u2013494. doi: 10.1517/17425255.2014.885016.", "ArticleIdList": ["10.1517/17425255.2014.885016", "24512004"]}, {"Citation": "Gali-Muhtasib H., Hmadi R., Kareh M., Tohme R., Darwiche N. Cell death mechanisms of plant-derived anticancer drugs: Beyond apoptosis. Apoptosis. 2015;20:1531\u20131562. doi: 10.1007/s10495-015-1169-2.", "ArticleIdList": ["10.1007/s10495-015-1169-2", "26362468"]}, {"Citation": "Sobarzo-S\u00e1nchez E., editor. Alkaloids: Biosynthesis, Biological Roles and Health Benefits. Nova Sciences Publishers; Hauppauge, NY, USA: 2015."}, {"Citation": "Xia J., Chen J., Zhang Z., Song P., Tang W., Kokudo N. A map describing the association between effective components of traditional Chinese medicine and signaling pathways in cancer cells in vitro and in vivo. Drug Discov. Ther. 2014;8:139\u2013153. doi: 10.5582/ddt.2014.01032.", "ArticleIdList": ["10.5582/ddt.2014.01032", "25262593"]}, {"Citation": "Saraste A., Pulkki K. Morphologic and biochemical hallmarks of apoptosis. Cardiovasc. Res. 2000;45:528\u2013537. doi: 10.1016/S0008-6363(99)00384-3.", "ArticleIdList": ["10.1016/S0008-6363(99)00384-3", "10728374"]}, {"Citation": "Elmore S. Apoptosis: A review of programmed cell death. Toxicol. Pathol. 2007;35:459\u2013516. doi: 10.1080/01926230701320337.", "ArticleIdList": ["10.1080/01926230701320337", "PMC2117903", "17562483"]}, {"Citation": "Nordin N., Majid N.A., Hashim N.M., Rahman M.A., Hassan Z., Ali H.M. Liriodenine, an aporphine alkaloid from Enicosanthellum pulchrum, inhibits proliferation of human ovarian cancer cells through induction of apoptosis via the mitochondrial signaling pathway and blocking cell cycle progression. Drug Des. Dev. Ther. 2015;9:1437\u20131448.", "ArticleIdList": ["PMC4362660", "25792804"]}, {"Citation": "Li L., Xu Y., Wang B. Liriodenine induces the apoptosis of human laryngocarcinoma cells via the upregulation of p53 expression. Oncol. Lett. 2014;15:1121\u20131127. doi: 10.3892/ol.2014.2834.", "ArticleIdList": ["10.3892/ol.2014.2834", "PMC4314988", "25663867"]}, {"Citation": "DeBono A., Capuano B., Scammells P.J. Progress Toward the Development of Noscapine and Derivatives as Anticancer Agents. J. Med. Chem. 2015;58:5699\u20135727. doi: 10.1021/jm501180v.", "ArticleIdList": ["10.1021/jm501180v", "25811651"]}, {"Citation": "Sajadian S., Vatankhah M., Majdzadeh M., Kouhsari S.M., Ghahremani M.H., Ostad S.N. Cell cycle arrest and apoptogenic properties of opium alkaloids noscapine and papaverine on breast cancer stem cells. Toxicol. Mech. Methods. 2015;25:388\u2013395. doi: 10.3109/15376516.2015.1045656.", "ArticleIdList": ["10.3109/15376516.2015.1045656", "25980655"]}, {"Citation": "Zhu H., Gooderham N.J. Mechanisms of induction of cell cycle arrest and cell death by cryptolepine in human lung adenocarcinoma A549 cells. Toxicol. Sci. 2006;91:132\u2013139. doi: 10.1093/toxsci/kfj146.", "ArticleIdList": ["10.1093/toxsci/kfj146", "16510557"]}, {"Citation": "Matsui T.A., Sowa Y., Murata H., Takagi K., Nakanishi R., Aoki S., Yoshikawa M., Kobayashi M., Sakabe T., Kubo T., et al. The plant alkaloid cryptolepine induces p21WAF1/CIP1 and cell cycle arrest in a human osteosarcoma cell line. Int. J. Oncol. 2007;31:915\u2013922. doi: 10.3892/ijo.31.4.915.", "ArticleIdList": ["10.3892/ijo.31.4.915", "17786325"]}, {"Citation": "Laryea D., Isaksson A., Wright C.W., Larsson R., Nygren P. Characterization of the cytotoxic activity of the indoloquinoline alkaloid cryptolepine in human tumour cell lines and primary cultures of tumour cells from patients. Investig. New Drugs. 2009;27:402\u2013411. doi: 10.1007/s10637-008-9185-5.", "ArticleIdList": ["10.1007/s10637-008-9185-5", "18853102"]}, {"Citation": "Waziri P.M., Abdullah R., Yeap S.K., Omar A.R., Kassim N.K., Malami I., How C.W., Etti I.C., Abu M.L. Clausenidin induces caspase-dependent apoptosis in colon cancer. BMC Complement. Altern. Med. 2016;16:256. doi: 10.1186/s12906-016-1247-1.", "ArticleIdList": ["10.1186/s12906-016-1247-1", "PMC4966865", "27473055"]}, {"Citation": "Schelz Z., Ocsovszki I., B\u00f3zsity N., Hohmann J., Zupko I. Antiproliferative Effects of Various Furanoacridones Isolated from Ruta graveolens on Human Breast Cancer Cell Lines. Anticancer Res. 2016;36:2751\u20132758.", "ArticleIdList": ["27272785"]}, {"Citation": "Uche F.I., Drijfhout F.P., McCullagh J., Richardson A., Wen L.W. Cytotoxicity Effects and Apoptosis Induction by Bisbenzylisoquinoline Alkaloids from Triclisia subcordata. Phytother. Res. 2016;30:1533\u20131539. doi: 10.1002/ptr.5660.", "ArticleIdList": ["10.1002/ptr.5660", "27270992"]}, {"Citation": "Wang X.D., Li C.Y., Jiang M.M., Li D., Wen P., Song X., Chen J.D., Guo L.X., Hu X.P., Li G.Q., et al. Induction of apoptosis in human leukemia cells through an intrinsic pathway by cathachunine, a unique alkaloid isolated from Catharanthus roseus. Phytomedicine. 2016;23:641\u2013653. doi: 10.1016/j.phymed.2016.03.003.", "ArticleIdList": ["10.1016/j.phymed.2016.03.003", "27161405"]}, {"Citation": "Li M., Li P., Zhang M., Ma F., Su L. Brucine inhibits the proliferation of human lung cancer cell line PC-9 via arresting cell cycle. Zhongguo Fei Ai Za Zhi. 2014;17:444\u2013450.", "ArticleIdList": ["PMC6000106", "24949683"]}, {"Citation": "Zheng L., Wang X., Luo W., Zhan Y., Zhang Y. Brucine, an effective natural compound derived from nux-vomica, induces G1 phase arrest and apoptosis in LoVo cells. Food Chem. Toxicol. 2013;58:332\u2013339. doi: 10.1016/j.fct.2013.05.011.", "ArticleIdList": ["10.1016/j.fct.2013.05.011", "23688861"]}, {"Citation": "Shu G., Mi X., Cai J., Zhang X., Yin W., Yang X., Li Y., Chen L., Deng X. Brucine, an alkaloid from seeds of Strychnos nux-vomica Linn., represses hepatocellular carcinoma cell migration and metastasis: The role of hypoxia inducible factor 1 pathway. Toxicol. Lett. 2013;222:91\u2013101. doi: 10.1016/j.toxlet.2013.07.024.", "ArticleIdList": ["10.1016/j.toxlet.2013.07.024", "23933019"]}, {"Citation": "Liew S.Y., Looi C.Y., Paydar M., Cheah F.K., Leong K.H., Wong W.F., Mustafa M.R., Litaudon M., Awang K. Subditine, a new monoterpenoid indole alkaloid from bark of Nauclea subdita (Korth.) Steud. Induces apoptosis in human prostate cancer cells. PLoS ONE. 2014;9:e87286. doi: 10.1371/journal.pone.0087286.", "ArticleIdList": ["10.1371/journal.pone.0087286", "PMC3925085", "24551054"]}, {"Citation": "Yang X.K., Xu M.Y., Xu G.S., Zhang Y.L., Xu Z.X. In Vitro and in Vivo Antitumor Activity of Scutebarbatine A on Human Lung Carcinoma A549 Cell Lines. Molecules. 2014;19:8740\u20138751. doi: 10.3390/molecules19078740.", "ArticleIdList": ["10.3390/molecules19078740", "PMC6270914", "24968330"]}, {"Citation": "Safia, Kamil M., Jadiya P., Sheikh S., Haque E., Nazir A., Lakshmi V., Mir S.S. The chromone alkaloid, Rohitukine, affords anti-cancer activity via modulating apoptosis pathways in A549 cell line and yeast mitogen activated protein kinase (MAPK) pathway. PLoS ONE. 2015;10:1\u201318. doi: 10.1371/journal.pone.0137991.", "ArticleIdList": ["10.1371/journal.pone.0137991", "PMC4583253", "26405812"]}, {"Citation": "Mansoor T.A., Borralho P.M., Dewanjee S., Mulhovo S., Rodrigues C.M.P., Ferreira M.J.U. Monoterpene bisindole alkaloids, from the African medicinal plant Tabernaemontana elegans, induce apoptosis in HCT116 human colon carcinoma cells. J. Ethnopharmacol. 2013;149:463\u2013470. doi: 10.1016/j.jep.2013.06.051.", "ArticleIdList": ["10.1016/j.jep.2013.06.051", "23872252"]}, {"Citation": "Lou C., Yokoyama S., Saiki I., Hayakawa Y. Selective anticancer activity of hirsutine against HER2positive breast cancer cells by inducing DNA damage. Oncol. Rep. 2015;33:2072\u20132076.", "ArticleIdList": ["25672479"]}, {"Citation": "Lou C., Takahashi K., Irimura T., Saiki I., Hayakawa Y. Identification of Hirsutine as an anti-metastatic phytochemical by targeting NF-\u03baB activation. Int. J. Oncol. 2014;45:2085\u20132091. doi: 10.3892/ijo.2014.2624.", "ArticleIdList": ["10.3892/ijo.2014.2624", "25175557"]}, {"Citation": "Fan Y., Patima A., Chen Y., Zeng F., He W., Luo L., Jie Y., Zhu Y., Zhang L., Lei J., Xie X., Zhang H. Cytotoxic effects of beta-carboline alkaloids on human gastric cancer SGC-7901 cells. Int. J. Clin. Exp. Med. 2015;8:12977\u201312982.", "ArticleIdList": ["PMC4612902", "26550217"]}, {"Citation": "Wang K.B., Li D.H., Hu P., Wang W.J., Lin C., Wang J., Lin B., Bai J., Pei Y.H., Jing Y.K., et al. A Series of \u03b2-Carboline Alkaloids from the Seeds of Peganum harmala Show G-Quadruplex Interactions. Org. Lett. 2016;18:3398\u20133401. doi: 10.1021/acs.orglett.6b01560.", "ArticleIdList": ["10.1021/acs.orglett.6b01560", "27340903"]}, {"Citation": "Zupk\u00f3 I., R\u00e9thy B., Hohmann J., Moln\u00e1r J., Ocsovszki I., Falkay G. Antitumor activity of alkaloids derived from amaryllidaceae species. In Vivo (Brooklyn) 2009;23:41\u201348.", "ArticleIdList": ["19368123"]}, {"Citation": "Shih Y.W., Shieh J.M., Wu P.F., Lee Y.C., Chen Y.Z. Alpha-tomatine inactivates PI3K/Akt and ERK signaling pathways in human lung adenocarcinoma A549 cells: Effect on metastasis. Food Chem. Toxicol. 2009;47:1985\u20131995. doi: 10.1016/j.fct.2009.05.011.", "ArticleIdList": ["10.1016/j.fct.2009.05.011", "19457446"]}, {"Citation": "Lee S.T., Wong P.F., Cheah S.C. Alpha-Tomatine Induces Apoptosis and Inhibits Nuclear Factor-Kappa B Activation on Human Prostatic Adenocarcinoma PC-3 Cells. PLoS ONE. 2011;6:e18915. doi: 10.1371/journal.pone.0018915.", "ArticleIdList": ["10.1371/journal.pone.0018915", "PMC3082542", "21541327"]}, {"Citation": "Jackson S.P., Bartek J. The DNA-damage response in human biology and disease. Nature. 2010;461:1071\u20131078. doi: 10.1038/nature08467.", "ArticleIdList": ["10.1038/nature08467", "PMC2906700", "19847258"]}, {"Citation": "Greenbaum L.E. Cell Cycle Regulation and Hepatocarcinogenesis. Cancer Biol. Ther. 2016;3:1200\u20131207. doi: 10.4161/cbt.3.12.1392.", "ArticleIdList": ["10.4161/cbt.3.12.1392", "15662121"]}, {"Citation": "Dickson M.A., Schwartz G.K. Development of cell-cycle inhibitors for cancer therapy. Curr. Oncol. 2009;16:36\u201343.", "ArticleIdList": ["PMC2669234", "19370178"]}, {"Citation": "Fruman D.A., Rommel C. PI3K and Cancer: Lessons, Challenges and Opportunities. Nat. Rev. Drug Discov. 2014;13:140\u2013156. doi: 10.1038/nrd4204.", "ArticleIdList": ["10.1038/nrd4204", "PMC3994981", "24481312"]}, {"Citation": "Zhang J.F., Liu J., Wang Y., Zhang B. Novel therapeutic strategies for patients with triple-negative breast cancer. Onco Targets Ther. 2016;9:6519\u20136528. doi: 10.2147/OTT.S105716.", "ArticleIdList": ["10.2147/OTT.S105716", "PMC5085278", "27799799"]}, {"Citation": "Jeong C.H., Joo S.H. Downregulation of Reactive Oxygen Species in Apoptosis. J Cancer Prev. 2016;21:13\u201320. doi: 10.15430/JCP.2016.21.1.13.", "ArticleIdList": ["10.15430/JCP.2016.21.1.13", "PMC4819661", "27051644"]}, {"Citation": "Devriese L.A., Witteveen P.E., Mergui-Roelvink M., Smith D.A., Lewis L.D., Mendelson D.S., Bang Y.J., Chung H.C., Dar M.M., Huitema A.D., et al. Pharmacodynamics and pharmacokinetics of oral topotecan in patients with advanced solid tumours and impaired renal function. Br. J. Clin. Pharmacol. 2014;80:253\u2013266. doi: 10.1111/bcp.12606.", "ArticleIdList": ["10.1111/bcp.12606", "PMC4541973", "25677219"]}, {"Citation": "Musa F., Blank S., Muggia F. Drug Evaluation A pharmacokinetic evaluation of topotecan as a cervical cancer therapy. Expert Opin. Drug Metab. Toxicol. 2013;9:215\u2013224. doi: 10.1517/17425255.2013.758249.", "ArticleIdList": ["10.1517/17425255.2013.758249", "23320990"]}, {"Citation": "Nicum S.J., O\u2019Brien M.E.R. Topotecan for the treatment of small-cell lung cancer. Expert Rev. Anticancer Ther. 2007;7:795\u2013801. doi: 10.1586/14737140.7.6.795.", "ArticleIdList": ["10.1586/14737140.7.6.795", "17555389"]}, {"Citation": "O\u2019Brien M.E.R., Eckardt J., Ramlau R. Recent advances with topotecan in the treatment of lung cancer. Oncologist. 2007;12:1194\u20131204. doi: 10.1634/theoncologist.12-10-1194.", "ArticleIdList": ["10.1634/theoncologist.12-10-1194", "17962613"]}, {"Citation": "Mcilwain D.R., Berger T., Mak T.W. Caspase Functions in Cell Death and Disease. Cold Spring Harb. Perspect. Biol. 2013;5:a0086562016. doi: 10.1101/cshperspect.a008656.", "ArticleIdList": ["10.1101/cshperspect.a008656", "PMC3683896", "23545416"]}, {"Citation": "Prokhorova E.A., Zamaraev A.V., Kopeina G.S., Zhivotovsky B., Lavrik I.N. Role of the nucleus in apoptosis: Signaling and execution. Cell. Mol. Life Sci. 2015;72:4593\u20134612. doi: 10.1007/s00018-015-2031-y.", "ArticleIdList": ["10.1007/s00018-015-2031-y", "26346492"]}, {"Citation": "Ghavami S., Hashemi M., Ande S.R., Yeganeh B., Xiao W., Eshraghi M., Bus C.J., Kadkhoda K., Wiechec E., Halayko J., et al. Apoptosis and cancer: Mutations within caspase genes. J. Med. Genet. 2009;46:497\u2013510. doi: 10.1136/jmg.2009.066944.", "ArticleIdList": ["10.1136/jmg.2009.066944", "19505876"]}, {"Citation": "Debatin K.M. Apoptosis pathways in cancer and cancer therapy. Cancer Immunol. Immunother. 2004;53:153\u2013159. doi: 10.1007/s00262-003-0474-8.", "ArticleIdList": ["10.1007/s00262-003-0474-8", "14749900"]}, {"Citation": "Giacinti C., Giordano A. RB and cell cycle progression. Oncogene. 2006;25:5220\u20135227. doi: 10.1038/sj.onc.1209615.", "ArticleIdList": ["10.1038/sj.onc.1209615", "16936740"]}, {"Citation": "Foster D.A., Yellen P., Xu L., Saqcena M. Regulation of G1 Cell Cycle Progression: Distinguishing the Restriction Point from a Nutrient-Sensing Cell Growth Checkpoint(s) Genes Cancer. 2010;1:1124\u20131131. doi: 10.1177/1947601910392989.", "ArticleIdList": ["10.1177/1947601910392989", "PMC3092273", "21779436"]}, {"Citation": "Visconti R., Della Monica R., Grieco D. Cell cycle checkpoint in cancer: A therapeutically targetable double-edged sword. J. Exp. Clin. Cancer Res. 2016;35:153. doi: 10.1186/s13046-016-0433-9.", "ArticleIdList": ["10.1186/s13046-016-0433-9", "PMC5037895", "27670139"]}, {"Citation": "Chabner B., Roberts T.G. Timeline: Chemotherapy and the war on cancer. Nat. Rev. Cancer. 2005;5:65\u201372. doi: 10.1038/nrc1529.", "ArticleIdList": ["10.1038/nrc1529", "15630416"]}, {"Citation": "Weaver B.A. How Taxol/paclitaxel kills cancer cells. Mol. Biol. Cell. 2014;25:2677\u20132681. doi: 10.1091/mbc.E14-04-0916.", "ArticleIdList": ["10.1091/mbc.E14-04-0916", "PMC4161504", "25213191"]}, {"Citation": "Holmsten K., Dohn L., Jensen N.V., Shah C.H., J\u00e4derling F., Pappot H., Ull\u00e9n A. Vinflunine treatment in patients with metastatic urothelial cancer: A Nordic retrospective multicenter analysis. Oncol. Lett. 2016;12:1293\u20131300. doi: 10.3892/ol.2016.4775.", "ArticleIdList": ["10.3892/ol.2016.4775", "PMC4950730", "27446429"]}, {"Citation": "Gourmelon C., Bourien H., Augereau P., Patsouris A., Frenel J.-S., Campone M. Vinflunine for the treatment of breast cancer. Expert Opin. Pharmacother. 2016;17:1817\u20131823. doi: 10.1080/14656566.2016.1217991.", "ArticleIdList": ["10.1080/14656566.2016.1217991", "27484180"]}, {"Citation": "Adhikari S., Dongol R., Hewett Y., Shah B.K., Joseph S., Medical R. Vincristine-induced blindness: A case report and review of literature. Anticancer Res. 2014;6734:6731\u20136733.", "ArticleIdList": ["25368282"]}, {"Citation": "Cooper G.M. The Cell: A Molecular Approach. 2nd ed. Sinauer Associates; Sunderland, MA, USA: 2000."}, {"Citation": "Weinberg R.A. The Biology of Cancer. 2nd ed. Garland Science; New York, NY, USA: 2013."}, {"Citation": "Sundaram V. RTK/Ras/MAPK signaling. WormBook. 2006:1\u201319. doi: 10.1895/wormbook.1.80.1.", "ArticleIdList": ["10.1895/wormbook.1.80.1", "PMC4780977", "18050474"]}, {"Citation": "Ma B., Hottiger M.O. Crosstalk between Wnt/\u03b2-Catenin and NF-\u03baB Signaling Pathway during Inflammation. Front. Immunol. 2016;7:378. doi: 10.3389/fimmu.2016.00378.", "ArticleIdList": ["10.3389/fimmu.2016.00378", "PMC5031610", "27713747"]}, {"Citation": "Bharti B.B.A., Alok C. Nuclear factor-kappa B and cancer: Its role in prevention and therapy. Biochem. Pharmacol. 2002;64:883\u2013888. doi: 10.1016/S0006-2952(02)01154-1.", "ArticleIdList": ["10.1016/S0006-2952(02)01154-1", "12213582"]}, {"Citation": "Kampan N.C., Madondo M.T., McNally O.M., Quinn M., Plebanski M. Paclitaxel and its evolving role in the management of ovarian cancer. Biomed. Res. Int. 2015;2015:413076. doi: 10.1155/2015/413076.", "ArticleIdList": ["10.1155/2015/413076", "PMC4475536", "26137480"]}, {"Citation": "Okamoto D.Y., Okamoto K. Structural insights into G-quadruplexes: Towards new anticancer drugs. Future Med. Chem. 2010;2:619\u2013646.", "ArticleIdList": ["PMC2886307", "20563318"]}, {"Citation": "Neidle S. Quadruplex Nucleic Acids as Novel Therapeutic Targets. J. Med. Chem. 2016;59:5987\u20136011. doi: 10.1021/acs.jmedchem.5b01835.", "ArticleIdList": ["10.1021/acs.jmedchem.5b01835", "26840940"]}, {"Citation": "Hartley J.A., Hochhauser D., Boone J.J., Bhosle J., Tilby M.J. Involvement of the HER2 pathway in repair of DNA damage produced by chemotherapeutic agents. Mol. Cancer Ther. 2009;8:3015\u20133023.", "ArticleIdList": ["19887555"]}, {"Citation": "Wink M., Ashour M.L., El-Readi M.Z. Secondary metabolites inhibiting ABC transporters and reversing resistance of cancer cells and fungi to cytotoxic and antimicrobial agents. Frontiers in Microbiology. Front. Microbiol. 2012;3:1\u201315. doi: 10.3389/fmicb.2012.00130.", "ArticleIdList": ["10.3389/fmicb.2012.00130", "PMC3332394", "22536197"]}, {"Citation": "Lin B., Li D., Zhang L. Oxymatrine mediates Bax and Bcl-2 expression in human breast cancer MCF-7 cells. Pharmazie. 2016;71:154\u2013157.", "ArticleIdList": ["27183711"]}, {"Citation": "Li J., Jiang K., Zhao F. Oxymatrine suppresses proliferation and facilitates apoptosis of human ovarian cancer cells through upregulating microRNA-29b and downregulating matrix metalloproteinase-2 expression. Mol. Med. Rep. 2015;12:5369\u20135374. doi: 10.3892/mmr.2015.3977.", "ArticleIdList": ["10.3892/mmr.2015.3977", "26099492"]}, {"Citation": "Hu W., Wu C., Huang W., Guo Y., Xia P., Sun X., Pan X. Oxymatrine inhibits the proliferation of prostate cancer cells in vitro and in vivo. Mol. Med. Rep. 2015;11:4129\u20134134.", "ArticleIdList": ["PMC4394963", "25672672"]}, {"Citation": "Huang J., Liang L. Oxymatrine inhibits epithelial-mesenchymal transition through regulation of NF-\u03baB signaling in colorectal cancer cells. Oncol. Rep. 2016;36:1333\u20131338.", "ArticleIdList": ["27430890"]}, {"Citation": "Zhu Y., Wang B., Han Q. Oxymatrine inhibited cell proliferation by inducing apoptosis in human lung cancer A549 cells. Biomed. Mater. Eng. 2015;26:S165\u2013S172.", "ArticleIdList": ["26405930"]}, {"Citation": "Guo B., Zhang T., Su J., Wang K., Li X. Oxymatrine targets EGFR(p-Tyr845) and inhibits EGFR-related signaling pathways to suppress the proliferation and invasion of gastric cancer cells. Cancer Chemother. Pharmacol. 2015;75:353\u2013363. doi: 10.1007/s00280-014-2651-1.", "ArticleIdList": ["10.1007/s00280-014-2651-1", "25527205"]}, {"Citation": "Li M., Su B.S., Chang L.H., Gao Q., Chen K.L., An P., Huang C., Yang J., Li Z.F. Oxymatrine induces apoptosis in human cervical cancer cells through guanine nucleotide depletion. Anticancer Drugs. 2014;25:161\u2013173. doi: 10.1097/CAD.0000000000000012.", "ArticleIdList": ["10.1097/CAD.0000000000000012", "24231526"]}, {"Citation": "Chen H., Zhang J., Luo J., Lai F., Wang Z., Tong H., Lu D., Bu H., Zhang R., Lin S. Antiangiogenic effects of oxymatrine on pancreatic cancer by inhibition of the NF-\u03baB-mediated VEGF signaling pathway. Oncol. Rep. 2013;30:589\u2013595.", "ArticleIdList": ["23754270"]}, {"Citation": "Liu Y., Bi T., Dai W., Wang G., Qian L., Gao Q., Shen G. Effects of Oxymatrine on the Proliferation and Apoptosis of Human Hepatoma Carcinoma Cells. Technol. Cancer Res. Treat. 2016;15:487\u2013497. doi: 10.1177/1533034615587616.", "ArticleIdList": ["10.1177/1533034615587616", "26009496"]}, {"Citation": "Ying X.J., Jin B., Chen X.W., Xie J., Xu H.M., Dong P. Oxymatrine downregulates HPV16E7 expression and inhibits cell proliferation in laryngeal squamous cell carcinoma Hep-2 cells in vitro. Biomed. Res. Int. 2015;2015:150390. doi: 10.1155/2015/150390.", "ArticleIdList": ["10.1155/2015/150390", "PMC4355122", "25811021"]}, {"Citation": "Zhang Y., Sun S., Chen J., Ren P., Hu Y., Cao Z., Sun H., Ding Y. Oxymatrine induces mitochondria dependent apoptosis in human osteosarcoma MNNG/HOS cells through inhibition of PI3K/Akt pathway. Tumour Biol. 2014;35:1619\u20131625. doi: 10.1007/s13277-013-1223-z.", "ArticleIdList": ["10.1007/s13277-013-1223-z", "24078465"]}, {"Citation": "Fei Z.W., Qiu M.K., Qi X.Q., Dai Y.X., Wang S.Q., Quan Z.W., Liu Y.B., Ou J.M. Oxymatrine suppresses proliferation and induces apoptosis of hemangioma cells through inhibition of HIF-1a signaling. Int. J. Immunopathol. Pharmacol. 2015;28:201\u2013208. doi: 10.1177/0394632015578342.", "ArticleIdList": ["10.1177/0394632015578342", "25816398"]}, {"Citation": "Pei Z., Zeng J., Gao Y., Li F., Li W., Zhou H., Yang Y., Wu R., Chen Y., Liu J. Oxymatrine inhibits the proliferation of CaSki cells via downregulating HPV16E7 expression. Oncol. Rep. 2016;36:291\u2013298.", "ArticleIdList": ["27176229"]}, {"Citation": "Bairagya H.R., Mukhopadhyay B.P., Bera A.K. Role of salt bridge dynamics in inter domain recognition of human IMPDH isoforms: An insight to inhibitor topology for isoform-II. J. Biomol. Struct. Dyn. 2011;29:441\u2013462. doi: 10.1080/07391102.2011.10507397.", "ArticleIdList": ["10.1080/07391102.2011.10507397", "22066532"]}, {"Citation": "Zhang Y., Piao B., Zhang Y., Hua B., Hou W., Xu W., Qi X., Zhu X., Pei Y., Lin H. Oxymatrine diminishes the side population and inhibits the expression of \u03b2-catenin in MCF-7 breast cancer cells. Med. Oncol. 2011;28:99\u2013107. doi: 10.1007/s12032-010-9721-y.", "ArticleIdList": ["10.1007/s12032-010-9721-y", "21069479"]}, {"Citation": "Srinivasan K. Black pepper and its pungent principle-piperine: A review of diverse physiological effects. Crit. Rev. Food Sci. Nutr. 2007;47:735\u2013748. doi: 10.1080/10408390601062054.", "ArticleIdList": ["10.1080/10408390601062054", "17987447"]}, {"Citation": "Yaffe P.B., Power Coombs M.R., Doucette C.D., Walsh M., Hoskin D.W. Piperine, an alkaloid from black pepper, inhibits growth of human colon cancer cells via G1 arrest and apoptosis triggered by endoplasmic reticulum stress. Mol. Carcinog. 2015;54:1070\u20131085. doi: 10.1002/mc.22176.", "ArticleIdList": ["10.1002/mc.22176", "24819444"]}, {"Citation": "Greenshields A.L., Doucette C.D., Sutton K.M., Madera L., Annan H., Yaffe P.B., Knickle A.F., Dong Z., Hoskin D.W. Piperine inhibits the growth and motility of triple-negative breast cancer cells. Cancer Lett. 2015;357:129\u2013140. doi: 10.1016/j.canlet.2014.11.017.", "ArticleIdList": ["10.1016/j.canlet.2014.11.017", "25444919"]}, {"Citation": "Zhang J., Zhu X., Li H., Li B., Sun L., Xie T., Zhu T., Zhou H., Ye Z. Piperine inhibits proliferation of human osteosarcoma cells via G2/M phase arrest and metastasis by suppressing MMP-2/-9 expression. Int. Immunopharmacol. 2015;24:50\u201358. doi: 10.1016/j.intimp.2014.11.012.", "ArticleIdList": ["10.1016/j.intimp.2014.11.012", "25479727"]}, {"Citation": "Ouyang D.Y., Zeng L.H., Pan H., Xu L.H., Wang Y., Liu K.P., He X.H. Piperine inhibits the proliferation of human prostate cancer cells via induction of cell cycle arrest and autophagy. Food Chem. Toxicol. 2013;60:424\u2013430. doi: 10.1016/j.fct.2013.08.007.", "ArticleIdList": ["10.1016/j.fct.2013.08.007", "23939040"]}, {"Citation": "Lin Y., Xu J., Liao H., Li L., Lin Y. Piperine induces apoptosis of lung cancer A549 cells via p53-dependent mitochondrial signaling pathway. Tumour Biol. 2014;35:3305\u20133310. doi: 10.1007/s13277-013-1433-4.", "ArticleIdList": ["10.1007/s13277-013-1433-4", "24272201"]}, {"Citation": "Yaffe P.B., Doucette C.D., Walsh M., Hoskin D.W. Piperine impairs cell cycle progression and causes reactive oxygen species-dependent apoptosis in rectal cancer cells. Exp. Mol. Pathol. 2013;94:109\u2013114. doi: 10.1016/j.yexmp.2012.10.008.", "ArticleIdList": ["10.1016/j.yexmp.2012.10.008", "23063564"]}, {"Citation": "Do M.T., Kim H.G., Choi J.H., Khanal T., Park B.H., Tran T.P., Jeong T.C., Jeong H.G. Antitumor efficacy of piperine in the treatment of human HER2-overexpressing breast cancer cells. Food Chem. 2013;141:2591\u20132599. doi: 10.1016/j.foodchem.2013.04.125.", "ArticleIdList": ["10.1016/j.foodchem.2013.04.125", "23870999"]}, {"Citation": "Prasad S., Tyagi A.K. Historical Spice as a Future Drug: Therapeutic Potential of Piperlongumine. Curr. Pharm. Des. 2016;22:4151\u20134159. doi: 10.2174/1381612822666160601103027.", "ArticleIdList": ["10.2174/1381612822666160601103027", "27262330"]}, {"Citation": "Duan C., Zhang B., Deng C., Cao Y., Zhou F., Wu L., Chen M., Shen S., Xu G., Zhang S., et al. Piperlongumine induces gastric cancer cell apoptosis and G2/M cell cycle arrest both in vitro and in vivo. Tumour Biol. 2016;37:10793\u201310804. doi: 10.1007/s13277-016-4792-9.", "ArticleIdList": ["10.1007/s13277-016-4792-9", "26874726"]}, {"Citation": "Kim T.H., Song J., Kim S.H., Parikh A.K., Mo X., Palanichamy K., Kaur B., Yu J., Yoon S.O., Nakano I., et al. Piperlongumine treatment inactivates peroxiredoxin 4, exacerbates endoplasmic reticulum stress, and preferentially kills high-grade glioma cells. Neuro Oncol. 2014;16:135\u2013164. doi: 10.1093/neuonc/nou088.", "ArticleIdList": ["10.1093/neuonc/nou088", "PMC4165421", "24879047"]}, {"Citation": "Bharadwaj U., Eckols T.K., Kolosov M., Kasembeli M.M., Adam A., Torres D., Zhang X., Dobrolecki L., Wei W., Lewis M.T., et al. Drug-repositioning screening identified piperlongumine as a direct STAT3 inhibitor with potent activity against breast cancer. Oncogene. 2015;34:1341\u20131353. doi: 10.1038/onc.2014.72.", "ArticleIdList": ["10.1038/onc.2014.72", "PMC4182178", "24681959"]}, {"Citation": "Niu M., Shen Y., Xu X., Yao Y., Fu C., Yan Z., Wu Q., Cao J., Sang W., Zeng L., et al. Piperlongumine selectively suppresses ABC-DLBCL through inhibition of NF-\u03baB p65 subunit nuclear import. Biochem. Biophys. Res. Commun. 2015;462:326\u2013331. doi: 10.1016/j.bbrc.2015.04.136.", "ArticleIdList": ["10.1016/j.bbrc.2015.04.136", "25979358"]}, {"Citation": "Golovine K., Makhov P., Naito S., Raiyani H., Tomaszewski J., Mehrazin R., Tulin A., Kutikov A., Uzzo R.G., Kolenko V.M. Piperlongumine and its analogs down-regulate expression of c-Met in renal cell carcinoma. Cancer Biol. Ther. 2015;16:743\u2013749. doi: 10.1080/15384047.2015.1026511.", "ArticleIdList": ["10.1080/15384047.2015.1026511", "PMC4623021", "25801713"]}, {"Citation": "Ginzburg S., Golovine K.V., Makhov P.B., Uzzo R.G., Kutikov A., Kolenko V.M. Piperlongumine inhibits NF-\u03baB activity and attenuates aggressive growth characteristics of prostate cancer cells. Prostate. 2014;74:177\u2013186. doi: 10.1002/pros.22739.", "ArticleIdList": ["10.1002/pros.22739", "PMC4052841", "24151226"]}, {"Citation": "Randhawa H., Kibble K., Zeng H., Moyer M.P., Reindl K.M. Activation of ERK signaling and induction of colon cancer cell death by piperlongumine. Toxicol. Vitr. 2013;27:1626\u20131633. doi: 10.1016/j.tiv.2013.04.006.", "ArticleIdList": ["10.1016/j.tiv.2013.04.006", "PMC3749270", "23603476"]}, {"Citation": "Zou P., Xia Y., Ji J., Chen W., Zhang J., Chen X., Rajamanickam V., Chen G., Wang Z., Chen L., et al. Piperlongumine as a direct TrxR1 inhibitor with suppressive activity against gastric cancer. Cancer Lett. 2015;375:114\u2013126. doi: 10.1016/j.canlet.2016.02.058.", "ArticleIdList": ["10.1016/j.canlet.2016.02.058", "26963494"]}, {"Citation": "Roh J.L., Kim E.H., Park J., Kim J.W., Kwon M., Lee B.H. Piperlongumine selectively kills cancer cells and increases cisplatin antitumor activity in head and neck cancer. Oncotarget. 2014;5:9227\u20139238. doi: 10.18632/oncotarget.2402.", "ArticleIdList": ["10.18632/oncotarget.2402", "PMC4253430", "25193861"]}, {"Citation": "DeVita V.T., Chu E. A history of cancer chemotherapy. Cancer Res. 2008;68:8643\u20138653. doi: 10.1158/0008-5472.CAN-07-6611.", "ArticleIdList": ["10.1158/0008-5472.CAN-07-6611", "18974103"]}, {"Citation": "Wei J., Zhu Y., Xu G., Yang F., Guan Z., Wang M., Fang Y. Oxymatrine extracted from Sophora flavescens inhibited cell growth and induced apoptosis in human osteosarcoma MG-63 cells in vitro. Cell Biochem. Biophys. 2014;70:1439\u20131444. doi: 10.1007/s12013-014-0078-2.", "ArticleIdList": ["10.1007/s12013-014-0078-2", "24997623"]}, {"Citation": "Bonavida B.E., Ng C.P., Jazirehi A., Schiller G.A., Mizutani Y.O. Selectivity of TRAIL-mediated apoptosis of cancer cells and synergy with drugs: The trail to non-toxic cancer therapeutics (review) Int. J. Oncol. 1999;15:793\u2013802. doi: 10.3892/ijo.15.4.793.", "ArticleIdList": ["10.3892/ijo.15.4.793", "10493964"]}, {"Citation": "Safarzadeh E., Shotorbani S.S., Baradaran B. Herbal medicine as inducers of apoptosis in cancer treatment. Adv. Pharm. Bull. 2014;4:421\u2013427.", "ArticleIdList": ["PMC4213780", "25364657"]}]}], "History": [{"Year": "2016", "Month": "12", "Day": "1"}, {"Year": "2017", "Month": "2", "Day": "1"}, {"Year": "2017", "Month": "2", "Day": "2"}, {"Year": "2017", "Month": "2", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "2", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "5", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "2", "Day": "8"}], "PublicationStatus": "epublish", "ArticleIdList": ["28208712", "PMC6155614", "10.3390/molecules22020250", "molecules22020250"]}}]}